Cramer's 'Mad Money' Recap: July 6

Wanted: IRA Government Bond

In a new segment called the "Eureka Moment," Cramer tackled the question: "Where do I invest my retirement savings?" He said that with so many lackluster options out there for investors, the answer is something completely new.

Cramer said those investing for retirement have a problem, if their only options are CDs and bonds that offer safety but no return, or stocks, which may offer a decent return, but are too risky for many people to handle right now.

The answer, he said, lies in the creation of a new 30-year, 5% government bond that's offered exclusively for IRAs and 401Ks.

Cramer said by offering investors a safe alternative that will allow them to double their money in just over 14 years, the government would be able to restore investor confidence while being able to fund problems for job creation. He pleaded to Congress, and to Treasury Secretary Tim Geithner, to consider creating such a bond to help spark savings and investment in our country.

Health Care That Works

Cramer welcomed David Snow, president, chairman and CEO of MedcoHealth Solutions (MHS Quote), to discuss the state of health care amidst talks of sweeping healthcare reforms.

Snow reiterated his belief that the debate in Washington should not be on who pays the bills for health care, but rather why the bills are so high in the first place. He said that 96% of all prescriptions in the U.S. are for chronic and complex diseases, the kinds that Medco manages better than anyone else around.

Snow also said that obesity and diabetes is an epidemic here in the U.S. and that with 50% of patients not following their doctors' instructions, the problem is turning a manageable disease into a very ugly situation.

Snow and Cramer also discussed how Medco is not often recognized for its innovations in personalized health solutions, or how the company has won over $16 billion worth of new business based on those innovations. Snow said he's shocked how that company's multiple is so low given its 15% to 20% growth rate.

Cramer reiterated his buy on MedcoHealth.